DK3442657T3 - Fremgangsmåde til evaluering af artikulære ledterapi - Google Patents

Fremgangsmåde til evaluering af artikulære ledterapi Download PDF

Info

Publication number
DK3442657T3
DK3442657T3 DK16898834.3T DK16898834T DK3442657T3 DK 3442657 T3 DK3442657 T3 DK 3442657T3 DK 16898834 T DK16898834 T DK 16898834T DK 3442657 T3 DK3442657 T3 DK 3442657T3
Authority
DK
Denmark
Prior art keywords
evaluation
procedure
articular joint
joint therapy
therapy
Prior art date
Application number
DK16898834.3T
Other languages
English (en)
Inventor
Kevin J Ruff
Original Assignee
Esm Tech Llc
Kevin J Ruff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esm Tech Llc, Kevin J Ruff filed Critical Esm Tech Llc
Application granted granted Critical
Publication of DK3442657T3 publication Critical patent/DK3442657T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16898834.3T 2016-04-15 2016-04-15 Fremgangsmåde til evaluering af artikulære ledterapi DK3442657T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/027789 WO2017180150A1 (en) 2016-04-15 2016-04-15 Method for evaluating articular joint therapeutics

Publications (1)

Publication Number Publication Date
DK3442657T3 true DK3442657T3 (da) 2022-10-03

Family

ID=60042860

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16898834.3T DK3442657T3 (da) 2016-04-15 2016-04-15 Fremgangsmåde til evaluering af artikulære ledterapi

Country Status (14)

Country Link
EP (1) EP3442657B1 (da)
JP (1) JP6768922B2 (da)
AU (1) AU2016402361B2 (da)
BR (1) BR112018071091A2 (da)
CA (1) CA3020688C (da)
DK (1) DK3442657T3 (da)
ES (1) ES2928171T3 (da)
HU (1) HUE060598T2 (da)
PL (1) PL3442657T3 (da)
PT (1) PT3442657T (da)
RS (1) RS63770B1 (da)
RU (1) RU2714312C1 (da)
SI (1) SI3442657T1 (da)
WO (1) WO2017180150A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12123873B2 (en) * 2018-04-03 2024-10-22 Sanofi Lateral flow immunoassay strip device
JP7421744B2 (ja) * 2019-08-28 2024-01-25 学校法人順天堂 変形性関節症の診断
KR102288646B1 (ko) * 2020-01-30 2021-08-11 충남대학교산학협력단 반려동물 골관절염 진단용 당사슬 바이오마커 및 이를 이용한 반려동물 골관절염 진단방법
KR102384149B1 (ko) * 2020-09-09 2022-04-08 아주대학교산학협력단 턱관절 골관절염 진단 또는 예후 예측용 바이오마커 조성물
CN114015762A (zh) * 2021-09-29 2022-02-08 温州医科大学附属第一医院 强直性脊柱炎诊断试剂盒及其应用
KR102829879B1 (ko) * 2023-03-16 2025-07-04 단국대학교 천안캠퍼스 산학협력단 소변 대사 산물을 이용한 유소년 운동 선수의 건강 상태 진단 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128270B1 (en) * 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
US20050124071A1 (en) 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
CA2540280A1 (en) * 2003-10-07 2005-04-21 Entelos, Inc. Simulating patient-specific outcomes
JP2008547006A (ja) * 2005-06-17 2008-12-25 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド 変形性関節症のタンパク質プロフィール
TW201337266A (zh) * 2005-11-01 2013-09-16 Abbott Biotech Ltd 利用生物標記診斷關節黏連脊椎炎之方法及組合物
BRPI0813262A2 (pt) * 2007-06-20 2015-04-14 Schering Corp Biomarcadores de destruição de articulação para terapia de doença inflamatória de articulação anti-il-17a
US20090299769A1 (en) * 2008-05-29 2009-12-03 Nordic Bioscience Imaging A/S Prognostic osteoarthritis biomarkers
WO2011102908A2 (en) * 2010-02-22 2011-08-25 Duke University Biomarkers of musculoskeletal disease
US8428045B2 (en) * 2010-03-16 2013-04-23 Harman International Industries, Incorporated Media clock recovery

Also Published As

Publication number Publication date
ES2928171T3 (es) 2022-11-15
WO2017180150A1 (en) 2017-10-19
RS63770B1 (sr) 2022-12-30
EP3442657B1 (en) 2022-07-27
CA3020688C (en) 2022-07-12
SI3442657T1 (sl) 2023-01-31
EP3442657A4 (en) 2019-10-16
HUE060598T2 (hu) 2023-03-28
RU2714312C1 (ru) 2020-02-14
JP6768922B2 (ja) 2020-10-14
AU2016402361B2 (en) 2022-08-11
CA3020688A1 (en) 2017-10-19
JP2019517007A (ja) 2019-06-20
BR112018071091A2 (pt) 2019-01-29
PL3442657T3 (pl) 2023-01-23
AU2016402361A1 (en) 2018-11-01
PT3442657T (pt) 2022-10-13
EP3442657A1 (en) 2019-02-20

Similar Documents

Publication Publication Date Title
EP3539514C0 (en) KNEE JOINT
DK3501542T3 (da) Esketamin til behandling af depression
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3286181T3 (da) Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3189082T3 (da) Anti-pd-l1-konjugater til behandling af tumorer
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
IL272851A (en) Methods of using dipivefrin
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3294720T3 (da) Fremgangsmåde til fremstilling af terpinolenepoxid
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
EP3514431A4 (en) THREAD PIPE CONNECTION
PT3645518T (pt) Síntese de omecamtiv mecarbil
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
EP3530828C0 (en) JOINT FITTING
DK3166628T3 (da) Terapeutisk anvendelse af knoglemorfogenetiske proteiner
EP3324894A4 (en) LATERAL AND MEDIAL SWITCHING KNEE PROSTHESIS
EP3437776A4 (en) CONNECTION STRUCTURE
EP3649988A4 (en) ARTIFICIAL KNEE JOINT
DK3347342T3 (da) Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner